Breast Cancer Aftercare Research Results
UKLC collected research data from lymphatic pressure therapists Anna Parsons, Juliette Cross, and Yvette Jordan.
The three years of research for new breast cancer aftercare called Lymphatic Pressure Therapy was presented at the 1st UK Lymphatic Science Meeting 2019. UKLC worked alongside Dr. Elizabeth Haining, a Research Fellow at the Institute of Cardiovascular Sciences. Dr. Haining who had collated our data declared the results `significant` by the three Asterix on the whisker charts seen below.
This means that LPT has now been documented and scientifically proven as a therapy for the very early treatment of sub-clinical lymphoedema.
UKLC truly believes and can now prove that early treatment works for improved patient survivorship and a better recovery outcome and none of the patients have since developed lymphoedema.
26 patients participated in this research and after only four weeks they saw a significant reduction of their arm, particularly in the upper arm.
Three measurements were taken at the beginning and end. No patient had been diagnosed with lymphoedema but experienced early stages of sub-clinical lymphoedema with limited mobility, pain and discomfort issues.
Since the research was presented, follow up has shown they have not developed lymphoedema and the effects of their treatment have lasted.
There are 9 ranges of movement in Lymphatic Pressure Therapy and as with the limb reduction, the 3 Asterix indicates a scientifically proven result.